BCRX

BCRX Change in Working Capital

-$71.66MTTM · USD

Period ending:

BCRX FY Change in Working CapitalUSD
BCRX FY Change in Working Capital1994-12-31: -$300.00K1995-12-31: $400.00K1996-12-31: $300.00K1997-12-31: -$500.00K1998-12-31: -$100.00K1999-12-31: -$300.00K2000-12-31: $333.18K2001-12-31: $948.04K2002-12-31: -$1.18M2003-12-31: $282.00K2004-12-31: $1.46M2005-12-31: $1.71M2006-12-31: $24.26M2007-12-31: -$3.00M2008-12-31: -$3.63M2009-12-31: -$9.90M2010-12-31: -$3.27M2011-12-31: $14.68M2012-12-31: -$4.30M2013-12-31: $3.81M2014-12-31: $1.31M2015-12-31: $19.02M2016-12-31: -$7.55M2017-12-31: $9.33M2018-12-31: -$3.53M2019-12-31: -$872.00K2020-12-31: $26.88M2021-12-31: $8.12M2022-12-31: -$58.95M2023-12-31: -$32.40M2024-12-31: -$87.28M2025-12-31: -$56.90M$26.88M-$87.28M
1994-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

BCRX change in working capital history

Working capital impact on cash flow. The available annual fiscal periods series contains 32 observations from Dec 31, 1994 to Dec 31, 2025.

Biocryst Pharmaceuticals Inc Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
-56,898,000
-87,282,000
-32,401,000
-58,945,000
8,124,000
26,875,000
-872,000
-3,530,000
9,327,000
-7,551,000
19,015,000
1,305,000
3,808,000
-4,299,000
14,683,000
-3,270,263
-9,904,332
-3,628,782
-3,003,016
24,257,467
1,708,000
1,462,571
282,000
-1,176,092
948,044
333,181
-300,000
-100,000
-500,000
300,000
400,000
-300,000

Compare change in working capital

All BCRX financial metrics · BCRX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.